IL1B and metastatic prostate carcinoma: Thus, these findings offer evidence for multiple roles exerted by IL-1β in promoting metastatic prostate cancer, similar to what was reported in bone tropic breast cancer [60,197,198,199], and provide the bedrock for targeting IL-1β signaling in both tumors as a novel treatment strategy.